Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 19/October/2014, 21.57

Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 19/October/2014, 21.57

Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of Interleukin-22, 19/October/2014, 21.57 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Interleukin-based therapy for Metabolic disorders: Lin-28 increases insulin sensitivity, restores mucosal immunity and decreases endotoxaemia via up regulation of  Interleukin-22, 19/October/2014, 21.57, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Significance: This study suggests, for the first time, that Lin28, by increasing the expression of IL-22, it may increase insulin sensitivity, restore gut immunity and decrease endotoxaemia. Together, this study suggests that pharmacological formulations encompassing “Lin28 activators” may be used to treat metabolic disorders, including T2DM and cardiac diseases.

Share
Natural product-based therapy for Mammary Cancer: Triptolide, a natural compound found in the herb Thunder of God vine, suppresses Mammary cancer cell migration and invasion via down regulation of Receptor for hyaluronan-mediated motility (RHAMM)/Hyaluronan-mediated motility receptor (HMMR), 02/October/2014, 12.31 pm
Molecular therapy for Inflammatory Bowel disease (IBD): E2F3 preserves the functions of Beclin 1 and ATG5 and decreases tissue injury in inflammatory bowel disease (IBD) via down regulation of its target gene, 08/February/2015, 23.32
Start Typing